This is not the most recent version of the article. View current version (19 DEC 2014)

Intervention Protocol

You have free access to this content

Creatine for women in pregnancy for neuroprotection of the fetus

  1. Emily Bain1,
  2. Dominic Wilkinson2,*,
  3. Philippa Middleton1,
  4. Caroline A Crowther1,3,
  5. Hayley Dickinson4,
  6. David W Walker4

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 26 NOV 2013

DOI: 10.1002/14651858.CD010846


How to Cite

Bain E, Wilkinson D, Middleton P, Crowther CA, Dickinson H, Walker DW. Creatine for women in pregnancy for neuroprotection of the fetus (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010846. DOI: 10.1002/14651858.CD010846.

Author Information

  1. 1

    The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia

  2. 2

    Women's and Children's Hospital, Department of Neonatal Medicine, Adelaide, SA, Australia

  3. 3

    The University of Auckland, Liggins Institute, Auckland, New Zealand

  4. 4

    Monash Institute of Medical Research, The Ritchie Centre, Melbourne, Victoria, Australia

*Dominic Wilkinson, Department of Neonatal Medicine, Women's and Children's Hospital, 72 King William Road, Adelaide, SA, 5006, Australia. dominic.wilkinson@adelaide.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 26 NOV 2013

SEARCH

This is not the most recent version of the article. View current version (19 DEC 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of creatine when used for neuroprotection of the fetus.